FindTrial
Sign In

Intravenous high concentration iodine contrast agent adverse reaction of patients study

Adverse reactions of patients intravenous high concentration iodine contrast agent study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082586
Enrollment
Unknown
Registered
2024-04-01
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adverse reaction of medicine

Interventions

Group of enhanced CT screening (intravenous 400mgI/ml contrast media):None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients volunteered to participate in this study, followed informed consent, =18 years old, glomerular filtration rate of > 30 ml/min/1.73m2, vascular enhanced CT examination, the iodine contrast administration rate were 5ml/s.

Exclusion criteria

Exclusion criteria: Excluding pregnant and lactating patients, patients who quit midway, patients with incomplete data, using nephrotoxic drugs, and patients taking metformin for diabetes.

Design outcomes

Primary

MeasureTime frame
glomerular filtration rate ;—

Secondary

MeasureTime frame
Adverse events;—

Countries

China

Contacts

Public ContactJing Qian

West China Hospital of Sichuan University

jq871209@126.com+86 135 4075 2891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026